Back to search

Article

COVID-19: Rapid Antigen detection for SARS-CoV-2 by lateral flow assay: a national systematic evaluation for mass-testing

2021-01-15

Abstract excerpt

Lateral flow device (LFD) viral antigen immunoassays have been developed around the world as diagnostic tests for SARS-CoV-2 infection. They have been proposed to deliver an infrastructure-light, cost-economical solution giving results within half an hour. Here we report on standardised laboratory evaluations of LFDs, and for those that met the published criteria, field testing in the Falcon-C19 research study and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b14a94db-82b2-5762-ba9d-8a43b4fc9d1d
DOI
10.1101/2021.01.13.21249563
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
COVID-19: Rapid Antigen detection for SARS-CoV-2 by lateral flow assay: a national systematic evaluation for mass-testingDOI 10.1101/2021.01.13.21249563
Comparative performance of SARS CoV-2 lateral flow antigen tests demonstrates their utility for high sensitivity detection of infectious virus in clinical specimensSemantic proximity
Performance of the Innova SARS-CoV-2 Antigen Rapid Lateral Flow Test in the Liverpool Asymptomatic Testing PilotSemantic proximity
Clinical and experimental factors that affect the reported performance characteristics of rapid testing for SARS-CoV-2Semantic proximity
Comparison of a prototype SARS-CoV-2 lateral flow immunoassay with the BinaxNOW™ COVID-19 Antigen CARDSemantic proximity
Validity of at-home rapid antigen lateral flow assay and artificial intelligence read to detect SARS-CoV-2Semantic proximity
Performance of Lateral Flow Assays for SARS-CoV-2 Compared to RT-qPCRSemantic proximity
Use cases for COVID-19 screening and surveillance with rapid antigen-detecting tests: a systematic reviewSemantic proximity
Multicentre diagnostic evaluation of OnSite COVID-19 Rapid Test (CTK Biotech) among symptomatic individuals in Brazil and The United KingdomSemantic proximity
Comparison of the analytical and clinical sensitivity of thirty-four rapid antigen tests with prevalent SARS-CoV-2 variants of concern during the COVID-19 pandemic in the UKSemantic proximity
Assessment of twenty-two SARS-CoV-2 rapid antigen tests against SARS-CoV-2: A laboratory evaluation studySemantic proximity
OraSure InteliSwab<sup>®</sup> Rapid Antigen Test performance with the SARS-CoV-2 Variants of Concern Alpha, Beta, Gamma, Delta, and OmicronSemantic proximity
Clinical evaluation of the Roche/SD Biosensor rapid antigen test with symptomatic, non-hospitalized patients in a municipal health service drive-through testing siteSemantic proximity
Select a neighboring publication to make it the new centre.